Acurx Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.19

+0.13 (+6.31%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +800.5% upside

Low Target $18.07

Average Target $19.72

High Target $32.84

Current Price $2.19

Current
$2.19

Target
$19.72

$18.07 $19.72 avg $32.84

Scenario Analysis

Bear Case

$18.07

725.1%

Low target

Base Case

$19.72

+800.5%

Avg target

Bull Case

$32.84

+1,399.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$26.57

-91.8% from high

52-Week Low

$10.57

+-79.3% from low

Target vs 52W High

$19.72

-25.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%